A clinical trial reported that ACE inhibitors reduced the likelihood of depression risk and significantly improved general well-being, work performance, and cognitive function in 625 white men with mild hypertension administered captopril for 6 months (210). The gene discussed is ACE; the disease is depressive symptom measurement.